Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Konrad Wiśniewski has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Enhanced Proteolytic and Glycooxidative Activity in Visceral Adipose Tissue in Obesity: A Tissue-Level Comparative Study

    by Konrad Wiśniewski, Barbara Choromańska, Mateusz Maciejczyk, Alan Tkaczuk, Andrzej Kupisz, Roman Cemaga, Jacek Dadan, Małgorzata Żendzian-Piotrowska, Anna Zalewska, Piotr Andrzej Myśliwiec

    Adipose tissue expansion in obesity is accompanied by extracellular matrix (ECM) remodeling, regulated by matrix metalloproteinases (MMPs). Visceral adipose tissue (VAT) is metabolically more active than subcutaneous adipose tissue (SAT). However, depot-specific differences in proteolytic activity and protein glycooxidation remain incompletely characterized. In this case–control study, we assessed the activity of six matrix metalloproteinases (MMP-1, -2, -7, -9, -11, and -13) using a fluorescence resonance energy transfer (FRET) assay and quantified advanced glycation- and glycooxidation-related markers in paired VAT, SAT, and plasma samples obtained from 40 patients with obesity and 21 non-obese controls. The activities of all assessed MMPs were greater in patients with obesity than in the control group (p < 0.01 for all MMPs). Direct tissue-compartment comparisons showed that MMP activity and glycooxidation-related markers were most pronounced in VAT, with markedly higher values in obese individuals compared with controls. In VAT of obese individuals, median MMP activity was approximately 50–60% higher compared with controls. Amyloid cross-β-structure, vesperlysine, and pentosidine were significantly elevated in VAT in obesity, whereas plasma levels were markedly lower and showed limited group differences. No significant differences were observed between obese participants with and without metabolic syndrome. Obesity is associated with a depot-specific molecular profile characterized by enhanced proteolytic and glycooxidative activity predominantly within visceral adipose tissue. These findings highlight the importance of tissue-compartment-specific assessment in obesity.

  • Open Access

    Enhanced Proteolytic and Glycooxidative Activity in Visceral Adipose Tissue in Obesity: A Tissue-Level Comparative Study

    by Konrad Wiśniewski, Barbara Choromańska, Mateusz Maciejczyk, Alan Tkaczuk, Kupisz Andrzej, Roman Cemaga, Jacek Dadan, Małgorzata Żendzian-Piotrowska, Anna Zalewska, Piotr Myśliwiec

    Background: Adipose tissue expansion in obesity is accompanied by extracellular matrix (ECM) remodelling, regulated by matrix metalloproteinases (MMPs). Visceral adipose tissue (VAT) is metabolically more active than subcutaneous adipose tissue (SAT). However, depot-specific differences in proteolytic activity and protein glycooxi-dation remain incompletely characterized. Methods: In this case-control study, we assessed the activity of six matrix metallo-proteinases (MMP-1, -2, -7, -9, -11, -13) using a fluorescence resonance energy transfer (FRET) assay and quantified advanced glycation and glycooxidation-related markers in paired VAT, SAT and plasma samples obtained from 40 patients with obesity and 21 non-obese controls. Results: The activities of all assessed MMPs were greater in patients with obesity than in the control group (p < 0.01 for all MMPs). Direct tissue-compartment comparisons showed that MMP activity and glycooxidation-related markers were most pronounced in VAT, with markedly higher values in obese individuals compared with controls. In VAT of obese individuals, median MMP activity was approximately 50–60% higher compared with controls. Amyloid cross-β-structure, vesperlysine and pentosidine were significantly elevated in VAT in obesity, whereas plasma levels were markedly lower and showed limited group differences. No significant differences were observed between obese par-ticipants with and without metabolic syndrome. Conclusions: Obesity is associated with a depot-specific molecular profile charac-terized by enhanced proteolytic and glycooxidative activity predominantly within vis-ceral adipose tissue. These findings highlight the importance of tissue-compartment–specific assessment in obesity.

  • Open Access

    Obesity as a Disease of Visceral Adipose Tissue: MMP Activation and AGE Accumulation as Key Mechanisms of Metabolic Complications

    by Konrad Wiśniewski, Barbara Choromańska, Mateusz Maciejczyk, Alan Tkaczuk, Andrzej Kupisz, Roman Cemaga, Jacek Dadan, Małgorzata Żendzian-Piotrowska, Anna Zalewska, Piotr Andrzej Myśliwiec

    Obesity is increasingly recognized as a chronic molecular disease of visceral adipose tissue rather than a simple excess of body weight. Structural remodeling and biochemical damage within adipose depots — particularly extracellular matrix (ECM) degradation and oxidative protein modification — are believed to play a central role in the development of metabolic complications. This study evaluated matrix metalloproteinase (MMP) activity and protein glycooxidation in visceral and subcutaneous adipose tissue, as well as plasma in individuals with obesity. Using a fluorescence resonance energy transfer (FRET)–based assay and fluorimetric quantification of advanced glycation end-products (AGEs), we demonstrated markedly increased activity of all analyzed MMPs (MMP-1, -2, -7, -9, -11, -13) and significantly higher accumulation of selected AGE-related structures (dityrosine (DT), amyloid cross-β-structure, vesperlysine (VES) , pentosidine (PEN)) in visceral adipose tissue of obese patients. These findings indicate that visceral adipose tissue forms a localized inflammatory–proteolytic microenvironment rather than a reflection of systemic circulating pathology. The coexistence of ECM degradation and glycooxidation may mechanistically promote insulin resistance and cardiometabolic risk. These findings suggest that clinical assessment of obesity may require more than anthropometric parameters and circulating biomarkers. Molecular profiling of visceral adipose tissue — directly or via future non-invasive surrogate markers — could improve patient stratification, support personalized metabolic risk prediction and optimize therapeutic decision-making.

  • Open Access

    Modulating Matrix Metalloproteinase Activity in Obesity: Comparative Effects of Bariatric Surgery and GLP-1/GIP-Based Pharmacotherapy

    by Konrad Wiśniewski, Barbara Choromańska, Mateusz Maciejczyk, Jacek Dadan, Piotr Myśliwiec

    Obesity is a multifactorial metabolic disease characterized by chronic low-grade inflammation, extracellular matrix (ECM) dysfunction, and systemic metabolic dysregulation. Matrix metalloproteinases (MMPs), especially MMP-2 and MMP-9, are key regulators of ECM remodeling and inflammation in obesity. This narrative review aimed to synthesize and critically discuss current evidence on the effects of bariatric surgery and pharmacological therapies, including GLP-1 and dual GLP-1/GIP receptor agonists, on MMP activity and metabolic outcomes. Literature from PubMed and Scopus and Web of Science (2015–2024) was analyzed, focusing on studies evaluating MMPs, inflammation, and metabolic parameters. Bariatric surgery consistently reduces MMP-9 levels and normalizes MMP-2 activity, contributing to improved ECM integrity, reduced inflammation, and enhanced insulin sensitivity. Pharmacological therapies achieve substantial weight loss and glycemic control, but evidence regarding their direct effects on MMP activity remains limited. This review highlights bariatric surgery as the most effective strategy for modulating obesity-related MMP dysregulation and emphasizes the need for further research into the mechanistic effects of modern pharmacotherapy on ECM remodeling.


  • Open Access

    Modulating Matrix Metalloproteinase Activity in Obesity: Comparative Effects of Bariatric Surgery and GLP-1/GIP-Based Pharmacotherapy

    by Konrad Wiśniewski, Barbara Choromańska, Mateusz Maciejczyk, Jacek Dadan, Piotr Andrzej Myśliwiec

    Obesity is a multifactorial metabolic disease characterized by chronic low-grade inflammation, extracellular matrix (ECM) dysfunction, and systemic metabolic dysregulation. Matrix metalloproteinases (MMPs), especially MMP-2 and MMP-9, are key regulators of ECM remodeling and inflammation in obesity. This narrative review aimed to synthesize current evidence on the effects of bariatric surgery and pharmacological therapies, including GLP-1 and dual GLP-1/GIP receptor agonists, on MMP activity and metabolic outcomes. Literature from PubMed and Scopus (2015–2024) was analyzed, focusing on studies evaluating MMPs, inflammation, and metabolic parameters. Bariatric surgery consistently reduces MMP-9 levels and normalizes MMP-2 activity, contributing to improved ECM integrity, reduced inflammation, and enhanced insulin sensitivity. Pharmacological therapies achieve substantial weight loss and glycemic control but evidence regarding their direct effects on MMP activity remains limited. This review highlights bariatric surgery as the most effective strategy for modulating obesity-related MMP dysregulation and emphasizes the need for further research into the mechanistic effects of modern pharmacotherapy on ECM remodeling.


  • Atypical Down syndrome and partial trisomy 21

    by E. C. Jenkins, C. J. Duncan, C. E. Wright, F. M. Giordano, L. Wilbur, K. Wisniewski, S. L. Sklower, J. H. French, C. Jones, W. T. Brown

    A case of "atypical" Down Syndrome (DS), where the proposita did not exhibit all of the clinical features of DS and had de novo partial trisomy 21, was studied. Results from phenotypic, chromosome banding and superoxide dismutase (SOD) gene dosage studies suggest a karyotype of 46,XX,-12,+t(12pter to 12qter::21q21 to 21q22.?2). Additional studies of such atypical cases will provide more precise sublocalization for both gene and phenotypic mapping of the bands that are responsible for the DS phenotype.


  • CLN -encoded proteins do not interact with each other

    by N. A. Zhong, D. N. Moroziewicz, W. Ju, K. E. Wisniewski, A. Jurkiewicz, W. T. Brown

    The lysosomal storage of lipofuscins is the common pathological feature that characterizes the infantile, late-infantile, juvenile (Batten's disease), and Finnish-variant neuronal ceroid lipofuscinosis (INCL, LINCL, JNCL and FNCL), which are due to mutations in the genes CLN1 , CLN2 , CLN3 , and CLN5 , respectively. The CLN1 and CLN2 genes encode lysosomal enzymes, but the CLN3 and CLN5 genes encode membrane-spanning proteins. Why deficiencies of lysosomal enzymes and membrane-spanning proteins produce similar clinical phenotypes and pathological changes is still unanswered. We hypothesize that CLN -encoded proteins may comprise a functional pathogenic pathway, in which protein associations may play important roles. To test this hypothesis, we studied protein-protein interactions among the CLN1 -, CLN2 -, and CLN3 -encoded proteins using a yeast two-hybrid system. Our results provided no evidence that CLN -encoded proteins interact with each other. This suggests there may be unidentified components in NCL pathogenesis.


  • The monocyte-macrophage system is affected in lysosomal storage diseases: an immunoelectron microscopic study

    by B. C. Kieseier, K. E. Wisniewski, H. H. Goebel

    Studying peripheral blood mononuclear cells (PBMCs) has become an important diagnostic tool in lysosomal storage diseases. Previous studies revealed that B and subclasses of T lymphocytes participate in the storage process, whereas the role of circulating monocytes was not clear. In this study, the involvement of CD14+ monocytes in lysosomal diseases was investigated. Blood samples from six patients with different lysosomal storage disorders were studied, including one with late-infantile and three with juvenile neuronal ceroid-lipofuscinoses, and two with mucopolysaccharidosis type VI. CD14+ cells were separated immunomagnetically from PBMCs and studied by light and electron microscopy. In all investigated disorders, disease-specific lysosomal storage material could be found in monocytes. The ratio of affected to non-affected cells did not differ from previously reported data on lymphocytes and their subforms in these diseases. Our data were obtained by studying a small number of different lysosomal storage disorders. Nevertheless, they suggest that lysosomal storage in the monocyte-macrophage system might also be found in other forms of lysosomal diseases.